Lineage Cell Therapeutics, Inc. Soared
Mon, May 24, 2021 at 05:32 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) jumped higher at $16.97, representing a gain of 21.3%. On Fri, May 21, 2021, BTX:NYSEMKT hit a New 2-Week Low of $13.99. The stock got featured on our News Catalysts scanner on Mon, May 24, 2021 at 03:10 PM in the 'INVESTOR UPDATE' category. From Fri, May 07, 2021, the stock recorded 10.00% Up Days and 18.18% Green Days
The stock spiked on Mon, May 03, 2021 at $80.67 with a volume of 31M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- SCPS (SCPS:NASDAQ), 71.98%
- MMA Capital Holdings, Inc. (MMAC:NASDAQ), 57.66%
- PTPI (PTPI:NASDAQ), 37.92%
- GSE Systems, Inc. (GVP:NASDAQ), 27.8%
- Virgin Galactic Holdings, Inc. (SPCE:NYSE), 27.62%
- KRBP (KRBP:NASDAQ), 25.4%
- Verastem, Inc. (VSTM:NASDAQ), 24.76%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 21.71%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 21.3%